WHILST there is little known about the pathology of agranulocytosis, little doubt can be entertained as to the part played by the sulphonamide compounds in its causation. Bigler, Clifton and WNerner (1938), Britton and Hawkins (1938) , and French (1939) Following the introduction of M&B 693, heavy dosage of the drug was recommended especially in the early stages of treatment, with the result that many "minor" toxic maniifestations (i.e., nausea, vomiting, headache, depression, etc.) were reported. The possibilities of more serious though less obvious toxic manifestations became apparent, and the desirability of evolving a scheme of dosage which would give the optimal clinical results with minimal toxic reactions presented itself. rhis wvas of particular importance not only generally, but in view of the fact that many of the patients treated were attending hospital as out-patients. An investigation was accordingly carriedl out personally with these objects in view. The cases investigated were chiefly out-patients being treated for gonorrhcea. The following are some of the results of this investigation.
PROCEDURE .
SixtN-one male patieints were investigatedl: fifty-nine were suffering from gonorrhcra and two from staphylococcal urinary infection. Of these, fifty were patients treate(I with 'M&B 693, seven were treated with Uleroni, and four were normal conitrols. Ihe fifty patients on M&B 69.3 were divided into three groups A, B, and C:-Group A.-This consists of forty-four out-patients who had the same dosage over a period of seven days (with occasional slight variations) ; during the first day they were given 3g. of the drug, whilst 2g. per cday were a(lministered thereafter for a further six days.
Group B.
-(iroup B3 consists of four patients to whom heavier dosage over a more proloniged period was adlministered as follows:-(I). Pt.Sh. 42.5g. in thirteeni days (in-patient suffering from epididyymitis). (II). Pt.L. 17.5g. in ten (lavs (ini-patient suffering from staphylococcal urinary infection and( para-urethral abscess).
(III). Pt. B. 24.0g. over a period of twenty-five days, which included seventeen days' interval (out-patient suffering from gonorrhoea) (IV). P't.Sc. 45 .0g. over a period of twenity-three days, which included three days' initerval (out-patient suffering from gonorrhoea).
Grou(p. C.-In two cases, a daily or bi-daily blood investigation was performed over a period of six days following single doses of M&B 693 of 4g. and 2g. respectively. The patients on Uleron were given 3g. of the drug per day for four days, followed by a period of seven to eight days' rest, when a second "stoss" similar to the first was administered, and, after a further interval of rest as before, a third "stoss" was given. The normal controls were four out-patients who were being treated by routine methods of urethral irrigations and mixed gonococcal vaccine.
Serial total and (lifferential white-cell counts and red-cell counts were made wZith ordinary standard pipettes, the hamoglobin being estimated by the Sahli method. In order to lessen the known daily fluctuations in the cell counts as much as possible, the counts were performed as nearly as possible at the same time each day, whilst to ensure the maximum degree of accuracy in the actual whitc-cell counts themselves, the following points were observed: (I Neutrophil polymorphonuclear leucocytes  -3,000-6,000  60-70  Lymphocytes  ----1,500-2,700  25-30  MonocN-tes   ----350-800  5-10 Eosinophil polymorphonuclear leucocytes -150-400 1-4 Basophil polymorphonuclear leucocytes -0-100 0-1 Anything above or below these figures was considered to be abnormal.
In the patients taking MI&B 693, blood investigations were performed whilst the drug was being taken and for a varying period thereafter up to the end of thirty-two days from the commencement of chemotherapy (and occasionally for an even longer period). In order to ascertain as nearly as possible the exact day on which the maximum effects, if any, vere seen, the investigations were carried out on different days on different patients, so that a fairly complete daily series was obtained during the period of examination. As the majoritv of bloodl counts were performed up to and including the twenty-second day from the beginning of chemotherapy, the results will be considered in detail only up to that day, but reference xwill be made to results obtained at an even later period. In the case of Uleron patients, blood investigations were performed before the beginning and at the end of each "stoss" and finally a week after the end of chemotherapy. lInvestigations were carried out at frequent intervals over a period of tw-o weeks on the control cases.
RESULTS.
Blood In view of the fincdings recor(led above, it was interesting to note that whilst the patient -who hadl the largest (lose of the series (45g. over a period of twenty-three days) shoxved somewhat similar changes in the white cells to those already observed, these changes were much less pronounced than one would have expected, and the blood picture had returned to normal several days before the end of chemotherapy. There was Ino subsequent fall in the number of cells during the following eighteen days, ancd in fact the neutrophils increased to over seventy per cent. of the total leucocytes and remainied high during the period of observation mentioned, following the with(drawal of the dcrug. This patient ha(d not responded to chemotherapy, and it was tempting to believe that possibly the drug was being poorly absorbed (unfortunately, the absorption and excretion were not investigated), and subsequently had little deleterious effect either on the organisms causing the disease, or on the blood-forming organs of the body. 87
An examiniiKationi of the effects of the (drLg on the blood in five patients in Group A who either did not respondl to chemotherapy or who showeed subsequent relapse, revealed somewhat similar changes in four cases to those noted in the majority of patients; in three of these, however, the changes wvere of a transient nature only. The fifth patienit showed no decrease in the number of the bloo(d cells at all.
An investigation was consequently ma(le in thosc patients in xvhom absorption and excretion of the drug had been simultaneously studied with the blood-cell changes, in order to see whether or not the changes in the blood cells varied in proportion to the concentration of the free drug in the blood. There was no constant relationship found between the two (see Table) .
i'lie patient xho received the second largest (lose (42.5g. in fifteen davs, Pt. S. in Iable) again showed similar changes to those in Group A., the maximum effect on blood cells being noticedl eleven days after withdrawal of the drug, when the neutrophils fell to 40.5 per cenit. of a total leucocvte count of 5,625, the lymphocyte count rising to 48.25 per cent.
Very similar eflects were observed in both of the other cases in this group. It was initeresting to note that the effects with the larger doscs were not necessarily more pronoUn1Ced than with the small dlosage which had been used for the patients in Group .\.
(roup C(-T7Wo Patients on a Single Dose of M&B 693.
In both of these cases variation was slight, though in one (following 2g.) there was a ten(leney to irregularity. As this patient's blood-cell counts were just on the border-line of normalitv at the beginning, it was (lifficult to be sure that any subsequent change was due to the drug.
Bloodl Cell Changes with Uleron. \Vhilst the niumLlber of cases of Uleron-treate(d patients which was studied was admittedly smaller than those on M.NI&B 693, it w\-as clear that Uleron had an even more marke(d toxic effect ont the white and red blood-cells than M&B 693, and that this effect was more noticeable at the end of the third "stoss" an(d continued for some days after withdrawal of the drug. The effect on the leucocytes was again chiefly due to a fall in the number of neutrophil polymorphonuclear cells, though the monocvtes also showed a greater numerical re(lICtion than with 'M&B 693. SeventN-one per cent of cases sho-wed leucopenia at some time or other, the lowest figure being 3 (1939) . Dolgopol and Hobart (1939) , however, in a fatal case of agranulocvtosis following .M&B 6983 (lescribed by them, found that, whilst the action of the drug on the bone-marrowz apparently coinsiste(d mainly in the arrest of maturationi of the leucopoietic elements, the ervthropoietic elements were also considerably affected. It has been mentionc(d that at least two cases of acute hemolvtic anwmia have been described by Long (1939) . The toxic effect, however, would appear to beimore markedl on the white-cell elemenits: that there is a definite tendency to a lowering of the total leucocvte count, and that this is due to a fall in the number of neutrophils, has been shown. That a similar phenomenon is observed after the administration of sulphanilamide has been recor(led bv Britton anld Hawkins (193, 8) and French (1939) , so that the action of \I&B 693 on the bloodl cells would appear to be essentially similar to that of sulphanilamide. Whilst the fall in the number of the total leucocvtes and the absolute neutropenia in the present series is rather less than that recorded by Britton and Hawkins (1938) , the dosage of M&B 693 is considerably smaller than that of sulphanilamide in the investigation made by these two workers. French (1939) found that only :33.3 per cent. of her sulphanilamide-treated cases gave a neutrophil-count below sixty per cent. of the total leucocytes. That M&B 693 has an even more toxic action on the white cells than sulphanilamide would seem to be indicated by the fact that eighty-three per cent. of cases in the present series exhibited a (crop at some time or other in the neutrophilcount to below sixty per cent. of the total leucocytes. This relative netutropenia, together with an accompanying relative lymphocytosis, was so marked that one almost came to regard it as a usual feature in patients who were being treated with M&B 693. Lloyd andl his associates (1938) noted a slight but definite fall in the total white blood-cell count with polvmorphonuclear leucopenia, and a relative lymphocvtosis in a few of their patients who were being treate(d with this drug unfortunately, they do not state the nunmber of patients in whom the investigation was carried out, nor the percenitage showing this phenomenon.
It is difficult to see just why this toxic effect on the red-cell elements on the one hand andI the white-cell elements on the other should be more marked in some patients thani others, and why in some cases it should proceedl to acute hwmolytic (Colebrook, 1939 ). It appears to be imiipossible to foretell just which patient is liable to develop a serious bloo(d dlvscrasia and wvhich is not. Ihat the onset of agnranulocytosis has been of such dranmatic su(ldenness that even repeated bloodl-cell counts have failed to indicate its approach has, unfortunately, been recordled with sulphanlilamide (Young, 1937) . Nexertlheless, a repeated blood-cell investigation shouldl form an integral part of sulphonaimii(le chemotherapy, especially where a dosage of 20g. or over (Pringle et al., 1940) is being given to a patient suflering from a condition likely itself to dlamage the bone-marrow. A number of other factors are significant in recor(le(l cases of agranulocytosis, and in particular it would seem to be of first importance to keep a close watch on the blood-cells of those patients who show undue signs of toxicity or an atypical response to the drug. IThat patients who do not show a rapidl response to chemotherapy arc unlikely to responid at all has been the experience of most workers. In such patienits, it seems evident that chemotherapy should be stopped anid other means of treatment instituted.
\With regar(d to the cell-counlts themselves, it has been dlemonstrated that the detrimeintal effect of MI&B 6983 continiues for somc days aIfter withclrawal of the drug, and that the maximuLm toxic effect is often seen (lurilig this period: in the investigation described, the grcatest effect was witnessed about nine days after cessation of chemotherapy and( sometimes even later. TIhis delayed efect has been the experience of other workers also (Barnett et al., 1939.) , (Graham et al., 1939) , (Agranat et al., 19:39, an(l Brig,-gs, 1939) . It is impor-tant, therefore, that where large dosage of the drug has been employed, and especially if there have been any signs of undue toxicity or unusual response to chemotherapy, the blood investigations should be continued for at least ten to fourteen days after the drug has been stopped. 
